It is a pharma private limited company based in Meghalaya, Meghalaya, India, established in 2003.
2003 | Meghalaya, Meghalaya, India | ActiveStadchem Pharma Private Limited, a active private limited company, was established on 30 May 2003 in Meghalaya, Meghalaya, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U51397ML2003PTC007113. Registered under ROC Roc Guwahati. it is unlisted. It has an authorized capital of ₹2.00 M and a paid-up capital of ₹1.70 M.
It upholds a compliant status. Employing 34 professional, Its leadership includes Suparna Bhattacharjee (Director), Sneha Bhattacharjee (Additional Director). Past directors included Bhaskar Bhattacharjee. It holds ₹2.60 Cr open charges and ₹2.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Quinton Road East Khasi Hills, Meghalaya, Meghalaya, 793001.
U51397ML2003PTC007113
007113
30 May 2003
₹2.00 M
₹1.70 M
Roc Guwahati
Unlisted
Active
Explore comprehensive insights into Stadchem Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suparna Bhattacharjee | Director | 30 May 2003 | Current |
| Sneha Bhattacharjee | Additional Director | 28 Nov 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 28 Nov 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Stadchem Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 14.75% increase. The company also saw a substantial fall in profitability, with a 189.22% decrease in profit. The company's net worth dipped by a decrease of 5.06%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Stadchem Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹26,000,000.00
₹2,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Jan 2022 | Uco Bank | ₹2.00 M | Open |
| 04 Jun 2020 | Uco Bank | ₹4.00 M | Open |
| 27 Jun 2006 | Uco Bank | ₹2.00 Cr | Open |
| 07 Apr 2020 | Uco Bank | ₹2.00 M | Satisfied |
Explore comprehensive loan charge details -
Stadchem Pharma has a workforce of 34 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Stadchem Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stadchem Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Sneha Bhattacharjee was appointed as a Additional Director was appointed as a Additional Director on 28 Nov 2024 & has been associated with this company since 1 year 21 days . was completed.
Stadchem Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Stadchem Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Guwahati. was documented.
Progress on A charge with Uco Bank amounted to Rs. 2.00 M with Charge ID 100528230 was registered on 03 Jan 2022. was documented.
The activity A charge registered on 07 Apr 2020 via Charge ID 100335039 with Uco Bank was fully satisfied on 11 Jun 2020. was completed.
The activity A charge with Uco Bank amounted to Rs. 4.00 M with Charge ID 100351430 was registered on 04 Jun 2020. was completed.
The CIN of Stadchem Pharma Private Limited is U51397ML2003PTC007113.
Stadchem Pharma Private Limited is headquartered at Quinton Road East Khasi Hills, Meghalaya, Meghalaya, 793001.
Stadchem Pharma Private Limited was incorporated on 30 May 2003.
The current directors of Stadchem Pharma Private Limited are
The primary industry of Stadchem Pharma Private Limited is Manufacturing.
Stadchem Pharma Private Limited is unlisted.
The authorized capital of Stadchem Pharma Private Limited is ₹2.00 M, and the paid-up capital is ₹1.70 M.
The compliance status of Stadchem Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX